Myriad Genetics (MYGN) Shareholder's Equity (2010 - 2026)

Myriad Genetics (MYGN) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 15.29 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 51.93 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn 52.95 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn 1.56 Bn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn -202.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 6.35 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn 1.77 Bn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn 2.68 Bn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn -41.88 Mn
10 Myriad Genetics 411.34 Mn 286.94 Mn 137.60 Mn 337.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 337.40 Mn
Dec 31, 2025 368.00 Mn
Sep 30, 2025 372.80 Mn
Jun 30, 2025 388.10 Mn
Mar 31, 2025 704.90 Mn
Dec 31, 2024 701.10 Mn
Sep 30, 2024 731.70 Mn
Jun 30, 2024 740.50 Mn
Mar 31, 2024 760.00 Mn
Dec 31, 2023 783.20 Mn
Sep 30, 2023 683.40 Mn
Jun 30, 2023 735.20 Mn
Mar 31, 2023 835.20 Mn
Dec 31, 2022 885.80 Mn
Sep 30, 2022 916.60 Mn
Jun 30, 2022 947.40 Mn
Mar 31, 2022 950.10 Mn
Dec 31, 2021 967.80 Mn
Sep 30, 2021 968.50 Mn
Jun 30, 2021 902.40 Mn